ANO1 and chronic obstructive pulmonary disease: demonstrated that niclosamide has a beneficial effect on constricted airways and mucus hypersecretion during airway inflammation by inhibiting airway TMEM16A.[108] Furthermore, niclosamide inhibits the progression of asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis by suppressing the release of IL‐8.[106] Braga et al.